Effects of topical azithromycin, moxifloxacin, and povidone iodine on conjunctival bacterial flora in patients undergoing intravitreal injection.


Journal

Arquivos brasileiros de oftalmologia
ISSN: 1678-2925
Titre abrégé: Arq Bras Oftalmol
Pays: Brazil
ID NLM: 0400645

Informations de publication

Date de publication:
Historique:
received: 28 02 2018
accepted: 03 06 2018
entrez: 18 1 2019
pubmed: 18 1 2019
medline: 11 4 2020
Statut: ppublish

Résumé

To compare effects of 5% topical povidone iodine with prophylactic topical azithromycin and moxifloxacin on bacterial flora in patients undergoing intravitreal injection. A total of 132 patients were randomly assigned to receive treatment with azithromycin or moxifloxacin, or no treatment (control group). In total, 528 specimens were obtained at the time of admission, 4 days before intravitreal injection, 4 days after intravitreal injection, and 8 days after intravitreal injection. Samples were immediately sent to the microbiology laboratory for incubation. The microorganism observed most frequently was coagulasenegative Staphylococcus (23.8%). When the results of samples obtained on Day 4 before injection were assessed, growth of coagulase-negative Staphylococcus was significantly lower in the moxifloxacin group, compared with controls (p=0.049). Acinetobacter baumannii continued to grow after administration of azithromycin (p=0.033). When the results of four days after intravitreal injection were evaluated, growth of coagulase-ne gative Staphylococcus was higher in controls, compared with patients who received azithromycin or moxifloxacin (p=0.004). Eradication rate was significantly higher in the moxifloxacin group than in the control group (p=0.001). Samples obtained on Day 8 after intravitreal injection showed similar levels of bacterial growth in all groups (p=0.217). Moxifloxacin was more effective than 5% povidone iodine in controlling the growth of conjunctival bacterial flora. Use of moxifloxacin in combination with 5% povidone iodine resulted in a synergistic effect.

Identifiants

pubmed: 30652764
pii: S0004-27492019000100025
doi: 10.5935/0004-2749.20190008
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents, Local 0
Azithromycin 83905-01-5
Povidone-Iodine 85H0HZU99M
Moxifloxacin U188XYD42P

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-31

Commentaires et corrections

Type : CommentIn

Auteurs

Kuddusi Teberik (K)

Department of Ophthalmology, Faculty of Medicine, Düzce University, Düzce, Turkey.

Mehmet Tahir Eski (MT)

Department of Ophthalmology, Ministry of Health Bingöl State Hospital, Bingöl, Turkey.

Emel Çalışkan (E)

Department of Medical Microbiology, Faculty of Medicine, Düzce University, Düzce, Turkey.

Özge Kılınçel (Ö)

Department of Medical Microbiology, Ataturk State Hospital, Düzce, Turkey.

Murat Kaya (M)

Department of Ophthalmology, Faculty of Medicine, Düzce University, Düzce, Turkey.

Handan Ankaralı (H)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH